Human Thyrotropin beta (Zelgen Biosciences)

人促甲状腺素β（泽璟生物）

Report date: 2026/04/15 20:02:38

Base Information

Drug NameHuman Thyrotropin beta (Zelgen Biosciences)
Drug Alias NamerhTSH重组人促甲状腺激素-泽璟生物Recombinant human thyroid stimulating hormone重组人TSH-泽璟生物Recombinant human thyrotropin (Zelgen Biosciences) +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionThyroid stimulating hormone receptor agonists
TargetsThyroid stimulating hormone receptor
Therapy Area/IndicationsThyroid Neoplasms
Global Approved IndicationsThyroid Neoplasms
Approved Indications in ChinaThyroid Neoplasms
Original Approved Country/TerritoryMainland China
Original Approved Date2026/01/05
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSuzhou Zelgen Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Zelgen Biopharmaceuticals Co LtdMerck KGaA, Darmstadt, Germany
Inactive CompaniesN/A
Active IndicationsThyroid Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A